IL17A and cancer: Several signaling pathways (e.g., cytokine–cytokine receptor interaction, TNF signaling, IL-17 signaling, FOXO signaling, pathways in cancer, PI3K-Akt signaling and Toll-like receptor signaling) were identified as significantly enriched in all comparison groups (Figure 3).